As Makary Exits, Pro-Lifers Await Movement On Abortion Drugs
Source Stacking
How They Deceive You
Propaganda
The article heavily misleads by presenting unverified claims and contested EPPC study data as settled facts while using loaded framing and exclusively pro-life sources.
Main Device
Source Stacking
Quotes only pro-life figures like Hawley, Rose, and Cassidy, with no pro-choice, FDA, or neutral experts to balance the narrative.
Archetype
Pro-life conservative advocate
Advances a right-wing agenda to restrict abortion drugs by framing FDA actions as malfeasance and Makary's exit as a pro-life win.
This article deceives by framing Makary's resignation as a pro-life victory through unverified claims, one-sided sourcing, and contested safety data as fact.
Writer's Worldview
“Pro-life conservative advocate”
8 findings · 3 omissions · 8 sources compared
What is your news hiding from you?
Same analysis. Any article. Completely free.
Narrative Analysis
Verdict: This Federalist article reports FDA Commissioner Marty Makary's resignation accurately but frames it as a pro-life "win" to advocate for abortion drug restrictions, relying on unverified claims, one-sided quotes, and contested safety data presented as fact.
Key Techniques and Evidence
The piece uses loaded framing and selective sourcing to build a narrative of FDA malfeasance and urgency for policy reversal:
- Unverified claims on successor and officials:
- Alleges acting FDA head Kyle Diamantas "represented Planned Parenthood of Greater Orlando in a 2017 legal dispute," implying pro-abortion bias. No court records or news confirm this; FDA bio lists his food safety role, and White House notes his recusal without details.
- Claims RFK Jr. "acknowledged under oath" Biden officials "twisted the data to bury" abortion pill safety signals. No testimony transcripts or reports match this quote.
- Contested safety data as fact:
- Cites EPPC study for "11 percent maternal injury rate" and risks "22 times higher than label," from "new data." EPPC is a conservative think tank; FDA label states risks occur "very rarely," with post-marketing data showing ~0.53 deaths per 100,000 users.
- One-sided sourcing:
- Quotes only pro-life advocates (e.g., Marjorie Dannenfelser: >"We look forward to a new FDA Commissioner who will put an end to the mail-order abortion drug regime"), Sen. Josh Hawley, Lila Rose. No FDA officials, medical experts, or counterviews.
- Loaded language:
- Terms like "mail-order abortion drug regime," "pro-abortion lawyers," "protect women from coercion and abuse," and "scheme" attribute unproven motives to policy without evidence.
These build pressure on Trump-era FDA without balancing evidence.
Verifiable Omissions and Impact
- Critiques of key safety study: The EPPC's 11% rate analysis has been challenged for methodological issues, like treating insurance claims as proven causation. ANSIRH (UCSF) and KFF reports note it overstates risks compared to FDA surveillance data. Matters because: Readers get no signal this is disputed, treating it as settled "new data."
- Full resignation context: Makary's exit followed Trump frustration over FDA delays on flavored vapes and pharma clashes, per NYT and Politico. Matters because: Article mentions rumors but centers pro-life pressure, obscuring other factors.
- Abortion trends: U.S. abortions rose slightly post-Dobbs (1.038M in 2024 to ~1.126M in 2025, Guttmacher data), but not as a "climbing" surge tied solely to mail-order pills. Matters because: Undercuts implied policy failure without disproving it.
Author and Outlet Context
Jordan Boyd, Federalist staff writer, focuses on conservative critiques of Democrats and pro-life issues. The Federalist, a right-leaning site, syndicates to Fox News and RealClearPolitics, prioritizing audience-aligned narratives.
Other Outlets' Coverage
Neutral outlets treated the resignation factually, without pro-life framing:
- AJMC: Brief announcement, no reasons or advocacy.
- ABC News: Notes clashes and Makary's reforms (e.g., COVID skepticism), with ally praise.
- Pharmacy Times: Frames as pressure-driven transition amid "internal turmoil."
- CNN/NPR: Highlight Trump tension or generic pill approvals, quoting conservatives but adding FDA defenses.
Bottom Line
The article credits pro-life reactions accurately and notes Trump's denial, doing solid reporting on the event timeline. But its advocacy slant—via unverified claims and imbalance—tips into persuasion over neutral analysis, potentially misleading on safety and motives. Stronger with sourced counterpoints.
Further Reading
Investigation Log · 58 steps
Starting investigation...
Investigating The Federalist
Investigating Jordan Boyd
Searching for ""Marty Makary" FDA commissioner resignation 2026"
Confirm Makary's resignation date and reasons reported elsewhere
Searching for "mifepristone maternal injury rate 11% OR "1 in 10" emergency room"
Verify the claim of 11% or 1 in 10 women suffering maternal injury or ER visit from mifepristone
Searching for ""Kyle Diamantas" Planned Parenthood FDA acting commissioner"
Verify Diamantas' past representation of Planned Parenthood
Source: The Federalist
The Federalist is an online magazine launched in September 2013 that publishes articles on politics, policy, culture, and religion, often with opinionated commentary. No media bias ratings from AllSides or MBFC or fact-checking track records appear in the provided search results. Its content prioritizes advocacy over neutral reporting, raising questions about incentives tied to engaging conservative audiences via provocative framing.
Source: Jordan Boyd
No provided search results identify a media source or author named "Jordan Boyd." All results describe athletes: a Georgia Tech football defensive lineman (6-3, 260 lbs, freshman in 2024 with 6 tackles), an Australian rules footballer for Carlton AFL (born 1998, debuted 2022, 40 games), and a Utah State men's basketball signee. Without relevant data, credibility as a media figure cannot be assessed.
Searching for ""Kyle Diamantas" "Planned Parenthood" OR PPGO OR "Planned Parenthood of Greater Orlando""
Verify if Diamantas represented Planned Parenthood in 2017 legal dispute
Searching for "EPPC mifepristone study critique OR debunked OR "11% adverse events" criticism"
Check credibility of the 11% maternal injury rate from EPPC study; look for counter-evidence or critiques
Searching for "mifepristone FDA label risk rate hemorrhage infection"
Verify the article's claim that the risk is 22 times higher than the drug’s label states
Searching for "FDA approves generic mifepristone October 2025"
Confirm FDA approval of generic abortion pill in Oct 2025
Searching for ""Robert F. Kennedy Jr" testimony Biden "twisted the data" mifepristone OR abortion pills"
Verify Kennedy's statement about Biden administration twisting data on abortion pill safety
Searching for "US abortion numbers trend 2024 2025 increase"
Verify claim of climbing number of U.S. abortions
Comparing coverage of "Marty Makary FDA resignation 2026"
Coverage comparison completed
unverified_claim
Claims Kyle Diamantas "represented Planned Parenthood of Greater Orlando in a 2017 legal dispute," citing court records, and implies pro-abortion ties via Lila Rose quote.
Creates alarm that the acting FDA head has pro-abortion history, pressuring for his replacement without evidence.
unverified_claim
States RFK Jr. "acknowledged under oath that the Biden administration 'twisted the data to bury one of the safety signals' associated with abortion pills."
Attributes serious accusation of data manipulation to HHS Secretary without basis, bolstering narrative of FDA negligence.
Source Credibility
Relies heavily on EPPC study for "11 percent maternal injury rate" and "22 times higher than label," presenting as settled fact from "new data."
EPPC is conservative think tank; study critiqued as "junk science" by ANSIRH, KFF, Guttmacher for methodological flaws (e.g., claims data not causation), inflating risks.
Missing Context
EPPC mifepristone study claiming 11% adverse events has been widely critiqued as methodologically flawed by ANSIRH (UCSF), KFF, and Guttmacher Institute.
Undermines article's portrayal of the 11% rate and related risks as undisputed "new data," providing balance to pro-life claims.
Source Credibility
Quotes only pro-life figures (Hawley, Dannenfelser, Rose, Cassidy, Hawkins) and anonymous sources; no pro-choice, FDA officials, or neutral experts.
Creates false consensus that Makary's resignation is a pro-life "win" and FDA must act on their demands.
Framing
Uses loaded terms like "mail-order abortion drug regime," "pro-abortion lawyers/FDA Commissioner," "protect women from coercion and abuse," "scheme to continue."
Mechanism-free moral labeling frames policy as abusive/illegal without evidence, smuggling anti-abortion conclusions into "reporting."
Missing Context
U.S. abortion numbers stable/slightly increased post-Dobbs (1.038M in 2024 to ~1.126M in 2025 per Guttmacher), not dramatically "climbing" as evidence of policy failure.
Contextualizes pro-life claim that mail-order mifepristone drives unsafe surge; actual trend predates expansions.
Searching for "AllSides OR MBFC "The Federalist" media bias rating"
Get precise bias rating for source.
Searching for "Jordan Boyd Federalist author background bias"
Confirm author background since prior search missed.
Comparing coverage of "mifepristone FDA review Trump Makary OR generic approval 2025"
Coverage comparison completed
Investigating The Federalist
Investigating Jordan Boyd The Federalist
Source Credibility
The Federalist is a right-leaning conservative outlet that consistently defends Republican policies and criticizes Democrats/pro-choice positions.
Indicates the article's framing prioritizes pro-life advocacy over neutral reporting on Makary's resignation.
unverified_claim
Claims '11 percent maternal injury rate' for mifepristone and '22 times higher than the drug’s label states' as established 'new data' from HHS/FDA review.
Presents contested, critiqued EPPC study as fact to justify demands for restrictions, alarming readers about safety.
Framing
Loaded terms: 'mail-order abortion drug regime,' 'pro-abortion lawyers/FDA Commissioner,' 'protect women from coercion/abuse,' 'scheme,' without evidence of widespread issues.
Mechanism-free moral labeling portrays policy as dangerous/abusive, smuggling pro-life conclusions into reporting.
Missing Context
Makary's resignation followed reports of Trump frustration over FDA resistance to approving flavored vapes and clashes with pharmaceutical companies, in addition to abortion pill issues.
Provides fuller context beyond pro-life framing; article mentions but buries.
Source: The Federalist
The Federalist is an online magazine focused on politics, policy, culture, and religion, with content primarily consisting of opinion pieces and analysis rather than straight news reporting, as evidenced by partisan headlines like 'Any Vote For Democrats Is Now A Vote For Their Plan To Overthrow SCOTUS' and 'Dems Lie About Trump Assassination Attempts'. No specific fact-checking track record or credibility ratings from AllSides or Media Bias/Fact Check appear in the provided search results. Its incentives appear tied to promoting conservative viewpoints, as self-described in the Knowledge Graph and reflected in consistently partisan framing.
Source: Jordan Boyd The Federalist
Jordan Boyd is a staff writer at The Federalist, described as 'award-winning,' with her work republished in The Daily Wire, Fox News, and RealClearPolitics. She produces 'The Federalist Radio Hour' and graduated from Baylor University with a political science major and journalism minor. While her output focuses on conservative policy critiques, no specific fact-checking records are available, and her role at a partisan outlet suggests incentives to prioritize audience-aligned narratives over neutral reporting.
Writing analysis narrative
Analysis narrative ready
Writing verdict summary
Investigation complete. Preparing report...
The Compass
You see how this outlet sees the world.
How do you see it? Find your political shape in a few minutes.
Take the testOr check your own article